Breaking News Instant updates and real-time market news.

PULM

Pulmatrix

$1.70 /

-0.09 (-5.03%)

18:53
03/19/19
03/19
18:53
03/19/19
18:53

Pulmatrix files to sell $27M of common stock, warrants

  • 19

    Mar

TODAY'S FREE FLY STORIES

Upgrade
Greenbrier upgraded to Neutral from Negative at Susquehanna » 06:17
07/13/20
07/13
06:17
07/13/20
06:17
GBX

Greenbrier

$25.07 /

+3.325 (+15.29%)

Susquehanna analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GBX Greenbrier
$25.07 /

+3.325 (+15.29%)

GBX Greenbrier
$25.07 /

+3.325 (+15.29%)

04/28/20 Susquehanna
Greenbrier downgraded to Negative from Neutral at Susquehanna
04/08/20 KeyBanc
Greenbrier price target lowered to $30 from $38 at KeyBanc
01/14/20 Wells Fargo
Greenbrier downgraded to Underweight from Equal Weight at Wells Fargo
11/08/19 Susquehanna
Greenbrier downgraded to Neutral from Positive at Susquehanna
GBX Greenbrier
$25.07 /

+3.325 (+15.29%)

GBX Greenbrier
$25.07 /

+3.325 (+15.29%)

Hot Stocks
Analog Devices, Maxim Integrated deal values combined enterprise at over $68B  06:17
07/13/20
07/13
06:17
07/13/20
06:17
ADI

Analog Devices

$124.42 /

+0.14 (+0.11%)

, MXIM

Maxim Integrated

$64.10 /

-0.33 (-0.51%)

 
ShowHide Related Items >><<
ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

MXIM Maxim Integrated
$64.10 /

-0.33 (-0.51%)

ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

06/30/20 SunTrust
Xilinx price target raised to $104 from $93 at SunTrust
05/21/20 Raymond James
Analog Devices price target raised to $125 from $100 at Raymond James
05/21/20 SunTrust
Analog Devices price target raised to $133 from $124 at SunTrust
05/21/20 RBC Capital
Analog Devices price target raised to $130 from $122 at RBC Capital
MXIM Maxim Integrated
$64.10 /

-0.33 (-0.51%)

04/29/20 Credit Suisse
Maxim Integrated price target lowered to $60 from $68 at Credit Suisse
03/30/20 Citi
Maxim Integrated price target lowered to $52 from $65 at Citi
03/20/20
Fly Intel: Top five analyst initiations
03/20/20 Nomura Instinet
Maxim Integrated initiated with a Neutral at Nomura Instinet
ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

MXIM Maxim Integrated
$64.10 /

-0.33 (-0.51%)

ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

MXIM Maxim Integrated
$64.10 /

-0.33 (-0.51%)

ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

Initiation
Aimmune initiated with an Outperform at Cowen » 06:16
07/13/20
07/13
06:16
07/13/20
06:16
AIMT

Aimmune

$15.67 /

+0.17 (+1.10%)

Cowen analyst Boris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AIMT Aimmune
$15.67 /

+0.17 (+1.10%)

AIMT Aimmune
$15.67 /

+0.17 (+1.10%)

06/08/20 Piper Sandler
Piper Sandler remains bullish on Aimmune after updated data for Palforzia
05/13/20 Credit Suisse
Aimmune price target lowered to $19 from $29 at Credit Suisse
05/12/20 H.C. Wainwright
Aimmune price target lowered to $15 from $30 at H.C. Wainwright
05/12/20 Stifel
Aimmune price target lowered to $20 from $32 at Stifel
AIMT Aimmune
$15.67 /

+0.17 (+1.10%)

AIMT Aimmune
$15.67 /

+0.17 (+1.10%)

AIMT Aimmune
$15.67 /

+0.17 (+1.10%)

Initiation
Royalty Pharma initiated with an Equal Weight at Morgan Stanley » 06:16
07/13/20
07/13
06:16
07/13/20
06:16
RPRX

Royalty Pharma

$47.55 /

-0.8 (-1.65%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPRX Royalty Pharma
$47.55 /

-0.8 (-1.65%)

06:15 Today SunTrust
Royalty Pharma initiated with a Buy at SunTrust
06:15 Today Cowen
Royalty Pharma initiated with an Outperform at Cowen
06:04 Today BofA
Royalty Pharma initiated with a Buy at BofA
07/12/20 Goldman Sachs
Royalty Pharma initiated with a Neutral at Goldman Sachs
  • 16
    Jun
RPRX Royalty Pharma
$47.55 /

-0.8 (-1.65%)

RPRX Royalty Pharma
$47.55 /

-0.8 (-1.65%)

Downgrade
Grupo Bimbo S.A.B. downgraded to Underweight from Equal Weight at Barclays » 06:16
07/13/20
07/13
06:16
07/13/20
06:16
GRBMF

Grupo Bimbo S.A.B.

$0.00 /

+ (+0.00%)

Barclays analyst Benjamin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRBMF Grupo Bimbo S.A.B.
$0.00 /

+ (+0.00%)

03/24/20 JPMorgan
Grupo Bimbo S.A.B. downgraded to Neutral from Overweight at JPMorgan
Initiation
Royalty Pharma initiated with a Buy at SunTrust » 06:15
07/13/20
07/13
06:15
07/13/20
06:15
RPRX

Royalty Pharma

$47.55 /

-0.8 (-1.65%)

SunTrust initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPRX Royalty Pharma
$47.55 /

-0.8 (-1.65%)

06:15 Today Cowen
Royalty Pharma initiated with an Outperform at Cowen
06:04 Today BofA
Royalty Pharma initiated with a Buy at BofA
07/12/20 Goldman Sachs
Royalty Pharma initiated with a Neutral at Goldman Sachs
  • 16
    Jun
RPRX Royalty Pharma
$47.55 /

-0.8 (-1.65%)

RPRX Royalty Pharma
$47.55 /

-0.8 (-1.65%)

Hot Stocks
NextCure provides interim update on Phase 2 NC318 monotherapy phase 1/2 trial » 06:15
07/13/20
07/13
06:15
07/13/20
06:15
NXTC

NextCure

$17.80 /

-0.4 (-2.20%)

NextCure provided an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NXTC NextCure
$17.80 /

-0.4 (-2.20%)

NXTC NextCure
$17.80 /

-0.4 (-2.20%)

06/01/20 Benchmark
NextCure downgraded to Hold from Buy at Benchmark
06/01/20 BofA
NextCure downgraded to Neutral from Buy at BofA
06/01/20 BofA
NextCure downgraded to Neutral from Buy at BofA
05/29/20 Piper Sandler
NextCure data shows S15-mediated activity, says Piper Sandler
NXTC NextCure
$17.80 /

-0.4 (-2.20%)

  • 15
    Nov
NXTC NextCure
$17.80 /

-0.4 (-2.20%)

Initiation
Royalty Pharma initiated with an Outperform at Cowen » 06:15
07/13/20
07/13
06:15
07/13/20
06:15
RPRX

Royalty Pharma

$47.55 /

-0.8 (-1.65%)

Cowen analyst Steve Scala…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPRX Royalty Pharma
$47.55 /

-0.8 (-1.65%)

06:04 Today BofA
Royalty Pharma initiated with a Buy at BofA
07/12/20 Goldman Sachs
Royalty Pharma initiated with a Neutral at Goldman Sachs
  • 16
    Jun
RPRX Royalty Pharma
$47.55 /

-0.8 (-1.65%)

RPRX Royalty Pharma
$47.55 /

-0.8 (-1.65%)

Downgrade
Redfin downgraded to Underperform from Neutral at BofA » 06:13
07/13/20
07/13
06:13
07/13/20
06:13
RDFN

Redfin

$37.12 /

-3 (-7.48%)

BofA analyst Nat…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RDFN Redfin
$37.12 /

-3 (-7.48%)

RDFN Redfin
$37.12 /

-3 (-7.48%)

07/10/20
Fly Intel: Top five analyst downgrades
07/09/20 RBC Capital
Redfin downgraded to Sector Perform from Outperform at RBC Capital
06/25/20 SunTrust
Redfin price target raised to $48 from $30 at SunTrust
06/11/20 DA Davidson
Redfin price target raised to $42 from $27 at DA Davidson
RDFN Redfin
$37.12 /

-3 (-7.48%)

RDFN Redfin
$37.12 /

-3 (-7.48%)

RDFN Redfin
$37.12 /

-3 (-7.48%)

Hot Stocks
Gravity: Ragnarok Origin hits top 4 on Google Play, Apple App store in Korea » 06:13
07/13/20
07/13
06:13
07/13/20
06:13
GRVY

Gravity

$53.82 /

-1.18 (-2.15%)

, GOOG

Alphabet

$1,542.06 /

+31.81 (+2.11%)

, GOOGL

Alphabet Class A

$1,540.69 /

+23.98 (+1.58%)

, AAPL

Apple

$383.56 /

+0.78 (+0.20%)

Gravity (GRVY) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOOG Alphabet
$1,542.06 /

+31.81 (+2.11%)

GOOGL Alphabet Class A
$1,540.69 /

+23.98 (+1.58%)

AAPL Apple
$383.56 /

+0.78 (+0.20%)

GRVY Gravity
$53.82 /

-1.18 (-2.15%)

GOOG Alphabet
$1,542.06 /

+31.81 (+2.11%)

07/09/20 Wedbush
Pinterest price target raised to $31 from $26 at Wedbush
07/07/20 BofA
Potential U.S. ban of TikTok could be tailwind to Snap engagement, says BofA
06/29/20 Stifel
Stifel says Facebook sales won't be materially hurt unless ad boycott broadens
06/25/20 Baird
Alphabet price target raised to $1,650 from $1,500 at Baird
GOOGL Alphabet Class A
$1,540.69 /

+23.98 (+1.58%)

07/09/20 Wedbush
Pinterest price target raised to $31 from $26 at Wedbush
07/07/20 BofA
Potential U.S. ban of TikTok could be tailwind to Snap engagement, says BofA
06/29/20 Stifel
Stifel says Facebook sales won't be materially hurt unless ad boycott broadens
06/25/20 Baird
Alphabet price target raised to $1,650 from $1,500 at Baird
AAPL Apple
$383.56 /

+0.78 (+0.20%)

07/09/20 Nomura Instinet
Nomura says Apple iPhone shipments in China pressured by 5G models in June
07/08/20 Deutsche Bank
'Nervous' Deutsche Bank raises Apple price target to $400 from $380
07/07/20 Raymond James
Apple price target raised to $400 from $340 at Raymond James
07/06/20 Loop Capital
Apple's build plan update negates speculation of cut, says Loop Capital
GRVY Gravity
$53.82 /

-1.18 (-2.15%)

GOOG Alphabet
$1,542.06 /

+31.81 (+2.11%)

GOOGL Alphabet Class A
$1,540.69 /

+23.98 (+1.58%)

AAPL Apple
$383.56 /

+0.78 (+0.20%)

GOOG Alphabet
$1,542.06 /

+31.81 (+2.11%)

GOOGL Alphabet Class A
$1,540.69 /

+23.98 (+1.58%)

AAPL Apple
$383.56 /

+0.78 (+0.20%)

GOOG Alphabet
$1,542.06 /

+31.81 (+2.11%)

GOOGL Alphabet Class A
$1,540.69 /

+23.98 (+1.58%)

AAPL Apple
$383.56 /

+0.78 (+0.20%)

GOOG Alphabet
$1,542.06 /

+31.81 (+2.11%)

GOOGL Alphabet Class A
$1,540.69 /

+23.98 (+1.58%)

AAPL Apple
$383.56 /

+0.78 (+0.20%)

GOOG Alphabet
$1,542.06 /

+31.81 (+2.11%)

GOOGL Alphabet Class A
$1,540.69 /

+23.98 (+1.58%)

AAPL Apple
$383.56 /

+0.78 (+0.20%)

Upgrade
DCP Midstream upgraded to Neutral from Sell at UBS » 06:13
07/13/20
07/13
06:13
07/13/20
06:13
DCP

DCP Midstream

$10.06 /

+0.285 (+2.92%)

UBS analyst Shneur…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DCP DCP Midstream
$10.06 /

+0.285 (+2.92%)

DCP DCP Midstream
$10.06 /

+0.285 (+2.92%)

06:00 Today UBS
DCP Midstream upgraded to Neutral from Sell at UBS
06/23/20 Jefferies
DCP Midstream, Phillips 66 and Holly Energy Partners cut to Hold at Jefferies
06/23/20 Jefferies
DCP Midstream downgraded to Hold from Buy at Jefferies
05/04/20 Mizuho
DCP Midstream price target lowered to $10 from $24 at Mizuho
DCP DCP Midstream
$10.06 /

+0.285 (+2.92%)

DCP DCP Midstream
$10.06 /

+0.285 (+2.92%)

Upgrade
KeyBanc upgrades Sunrun to Overweight on Vivint merger » 06:13
07/13/20
07/13
06:13
07/13/20
06:13
RUN

Sunrun

$28.88 /

+1.06 (+3.81%)

, VSLR

Vivint Solar

$15.98 /

+0.66 (+4.31%)

, NOVA

Sunnova Energy

$19.05 /

-0.065 (-0.34%)

KeyBanc analyst Sophie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RUN Sunrun
$28.88 /

+1.06 (+3.81%)

VSLR Vivint Solar
$15.98 /

+0.66 (+4.31%)

NOVA Sunnova Energy
$19.05 /

-0.065 (-0.34%)

RUN Sunrun
$28.88 /

+1.06 (+3.81%)

04:44 Today KeyBanc
Sunrun upgraded to Overweight from Sector Weight at KeyBanc
07/08/20 Roth Capital
Sunrun, Vivint combined entity results in substantial scale, says Roth Capital
07/08/20 Roth Capital
Vivint Solar acquisition by Sunrun could drive costs lower, says Roth Capital
07/08/20 Oppenheimer
Vivint Solar moved to Not Rated at Oppenheimer after acquisition by Sunrun
VSLR Vivint Solar
$15.98 /

+0.66 (+4.31%)

07/08/20 Roth Capital
Sunrun, Vivint combined entity results in substantial scale, says Roth Capital
07/08/20 Roth Capital
Vivint Solar acquisition by Sunrun could drive costs lower, says Roth Capital
07/08/20 Oppenheimer
Vivint Solar moved to Not Rated at Oppenheimer after acquisition by Sunrun
07/07/20 JMP Securities
Vivint Solar downgraded to Market Perform from Outperform at JMP Securities
NOVA Sunnova Energy
$19.05 /

-0.065 (-0.34%)

06/29/20
Sunnova Energy files to sell 8M shares of common stock
06/15/20 Credit Suisse
Sunnova Energy upgraded to Outperform from Neutral at Credit Suisse
06/02/20 Roth Capital
Roth says loan securitizations reopening a positive for residential solar names
05/28/20 JPMorgan
Sunnova Energy price target raised to $20 from $18 at JPMorgan
RUN Sunrun
$28.88 /

+1.06 (+3.81%)

VSLR Vivint Solar
$15.98 /

+0.66 (+4.31%)

NOVA Sunnova Energy
$19.05 /

-0.065 (-0.34%)

  • 01
    Jul
  • 25
    Jul
VSLR Vivint Solar
$15.98 /

+0.66 (+4.31%)

RUN Sunrun
$28.88 /

+1.06 (+3.81%)

VSLR Vivint Solar
$15.98 /

+0.66 (+4.31%)

NOVA Sunnova Energy
$19.05 /

-0.065 (-0.34%)

RUN Sunrun
$28.88 /

+1.06 (+3.81%)

VSLR Vivint Solar
$15.98 /

+0.66 (+4.31%)

Initiation
AllianceBernstein initiated with an Outperform at Evercore ISI » 06:13
07/13/20
07/13
06:13
07/13/20
06:13
AB

AllianceBernstein

$26.91 /

+0.17 (+0.64%)

Evercore ISI analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AB AllianceBernstein
$26.91 /

+0.17 (+0.64%)

AB AllianceBernstein
$26.91 /

+0.17 (+0.64%)

05:41 Today Evercore ISI
AllianceBernstein initiated with an Outperform at Evercore ISI
03/23/20 BofA
BofA cuts Apollo, Carlyle, AllianceBernstein and upgrades Charles Schwab
03/23/20 BofA
AllianceBernstein downgraded to Neutral from Buy at BofA
01/13/20 Citi
Citi opens '90 Day Positive Catalyst Watch' on Sculptor Capital
AB AllianceBernstein
$26.91 /

+0.17 (+0.64%)

AB AllianceBernstein
$26.91 /

+0.17 (+0.64%)

Upgrade
Nutrien upgraded to Buy from Underperform at BofA » 06:11
07/13/20
07/13
06:11
07/13/20
06:11
NTR

Nutrien

$31.71 /

+0.41 (+1.31%)

BofA analyst Steve Byrne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTR Nutrien
$31.71 /

+0.41 (+1.31%)

NTR Nutrien
$31.71 /

+0.41 (+1.31%)

06/19/20 JPMorgan
Nutrien price target lowered to $40 from $44 at JPMorgan
05/14/20 Consumer Edge
Nutrien downgraded to Equal Weight from Overweight at Consumer Edge
05/11/20 BofA
Nutrien, Mosaic, Corteva, CF Industries cut to Underperform at BofA
05/11/20 BofA
Nutrien downgraded to Underperform from Buy at BofA
NTR Nutrien
$31.71 /

+0.41 (+1.31%)

NTR Nutrien
$31.71 /

+0.41 (+1.31%)

NTR Nutrien
$31.71 /

+0.41 (+1.31%)

Upgrade
CF Industries upgraded to Buy from Underperform at BofA » 06:11
07/13/20
07/13
06:11
07/13/20
06:11
CF

CF Industries

$28.12 /

+1.225 (+4.55%)

BofA analyst Steve Byrne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CF CF Industries
$28.12 /

+1.225 (+4.55%)

CF CF Industries
$28.12 /

+1.225 (+4.55%)

05/11/20 BofA
Nutrien, Mosaic, Corteva, CF Industries cut to Underperform at BofA
05/11/20 BofA
CF Industries double-downgraded to Underperform from Buy at BofA
05/11/20 BofA
CF Industries downgraded to Underperform from Buy at BofA
04/28/20 Cleveland Research
Nutrien, CF Industries estimates cut at Cleveland Research
CF CF Industries
$28.12 /

+1.225 (+4.55%)

CF CF Industries
$28.12 /

+1.225 (+4.55%)

CF CF Industries
$28.12 /

+1.225 (+4.55%)

Hot Stocks
CytoDyn gets Refusal to File letter from FDA on BLA for leronlimab » 06:10
07/13/20
07/13
06:10
07/13/20
06:10
CYDY

CytoDyn

$0.00 /

+ (+0.00%)

CytoDyn announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYDY CytoDyn
$0.00 /

+ (+0.00%)

CYDY CytoDyn
$0.00 /

+ (+0.00%)

07/06/20 H.C. Wainwright
CytoDyn downgraded to Neutral from Buy at H.C. Wainwright
04/28/20 H.C. Wainwright
CytoDyn price target raised to $4 from $3 at H.C. Wainwright
04/03/20 H.C. Wainwright
CytoDyn price target raised to $3 from $1.50 at H.C. Wainwright
12/19/19 H.C. Wainwright
CytoDyn price target raised to $1.50 from $1.00 at H.C. Wainwright
CYDY CytoDyn
$0.00 /

+ (+0.00%)

Periodicals
Target, MTV block ads in stories related to BLM movement, WSJ reports » 06:10
07/13/20
07/13
06:10
07/13/20
06:10
TGT

Target

$118.88 /

+0.98 (+0.83%)

, VIAC

ViacomCBS

$22.94 /

+0.83 (+3.75%)

, VIACA

ViacomCBS

$25.25 /

+0.94 (+3.87%)

Target (TGT) last month…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TGT Target
$118.88 /

+0.98 (+0.83%)

VIAC ViacomCBS
$22.94 /

+0.83 (+3.75%)

VIACA ViacomCBS
$25.25 /

+0.94 (+3.87%)

TGT Target
$118.88 /

+0.98 (+0.83%)

07/12/20 Jefferies
Walmart/Target e-comm growth not seen coming at Amazon's expense, says Jefferies
06/24/20 B. Riley FBR
Hanesbrands products largely sold out at Walmart and Target, says B. Riley FBR
06/19/20 Cleveland Research
Target upgraded to Buy from Neutral at Cleveland Research
05/21/20 Deutsche Bank
Target price target raised to $131 from $121 at Deutsche Bank
VIAC ViacomCBS
$22.94 /

+0.83 (+3.75%)

05:05 Today Goldman Sachs
ViacomCBS initiated with a Buy at Goldman Sachs
06/26/20 Needham
ViacomCBS price target raised to $30 from $20 at Needham
06/23/20 Citi
ViacomCBS price target raised to $27 from $20 at Citi
06/19/20 Macquarie
ViacomCBS price target raised to $26 from $18 at Macquarie
VIACA ViacomCBS
$25.25 /

+0.94 (+3.87%)

04/07/20 Barrington
ViacomCBS downgraded to Market Perform from Outperform at Barrington
TGT Target
$118.88 /

+0.98 (+0.83%)

VIAC ViacomCBS
$22.94 /

+0.83 (+3.75%)

VIACA ViacomCBS
$25.25 /

+0.94 (+3.87%)

TGT Target
$118.88 /

+0.98 (+0.83%)

VIAC ViacomCBS
$22.94 /

+0.83 (+3.75%)

VIACA ViacomCBS
$25.25 /

+0.94 (+3.87%)

TGT Target
$118.88 /

+0.98 (+0.83%)

VIAC ViacomCBS
$22.94 /

+0.83 (+3.75%)

VIACA ViacomCBS
$25.25 /

+0.94 (+3.87%)

TGT Target
$118.88 /

+0.98 (+0.83%)

VIAC ViacomCBS
$22.94 /

+0.83 (+3.75%)

Upgrade
Corteva upgraded to Buy from Underperform at BofA » 06:10
07/13/20
07/13
06:10
07/13/20
06:10
CTVA

Corteva

$26.62 /

+0.875 (+3.40%)

BofA analyst Steve Byrne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTVA Corteva
$26.62 /

+0.875 (+3.40%)

CTVA Corteva
$26.62 /

+0.875 (+3.40%)

06/26/20 Cleveland Research
Corteva initiated with a Neutral at Cleveland Research
06/26/20 Cleveland Research
Corteva initiated with a Neutral at Cleveland Research
06/16/20 Vertical Research
Corteva upgraded to Buy from Hold at Vertical Research
06/08/20 Monness Crespi
Corteva downgraded to Sell from Neutral at Monness Crespi
CTVA Corteva
$26.62 /

+0.875 (+3.40%)

CTVA Corteva
$26.62 /

+0.875 (+3.40%)

CTVA Corteva
$26.62 /

+0.875 (+3.40%)

Initiation
Jefferies starts Moderna with Buy rating, $90 price target » 06:10
07/13/20
07/13
06:10
07/13/20
06:10
MRNA

Moderna

$62.57 /

-2.38 (-3.66%)

Jefferies analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$62.57 /

-2.38 (-3.66%)

MRNA Moderna
$62.57 /

-2.38 (-3.66%)

07/08/20 Piper Sandler
Piper reiterates $100 target on Moderna after Phase II study enrolled
07/02/20 BMO Capital
Moderna mRNA platform supported by Pfizer vaccine data, says BMO Capital
06/30/20 Argus
Moderna initiated with a Buy at Argus
06/30/20 Argus
Moderna initiated with a Buy at Argus
MRNA Moderna
$62.57 /

-2.38 (-3.66%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$62.57 /

-2.38 (-3.66%)

MRNA Moderna
$62.57 /

-2.38 (-3.66%)

MRNA Moderna
$62.57 /

-2.38 (-3.66%)

Hot Stocks
Amdocs expands agreement with PLDT » 06:09
07/13/20
07/13
06:09
07/13/20
06:09
DOX

Amdocs

$59.01 /

+1.22 (+2.11%)

, PHI

PLDT

$27.67 /

-0.38 (-1.35%)

Amdocs (DOX) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DOX Amdocs
$59.01 /

+1.22 (+2.11%)

DOX Amdocs
$59.01 /

+1.22 (+2.11%)

02/05/20 Oppenheimer
Amdocs price target raised to $85 from $77 at Oppenheimer
11/15/19 Stifel
Amdocs price target raised to $75 from $70 at Stifel
08/08/19 JPMorgan
Amdocs price target raised to $75 from $67 at JPMorgan
PHI PLDT
$27.67 /

-0.38 (-1.35%)

03/25/20 JPMorgan
PLDT upgraded to Overweight from Neutral at JPMorgan (yesterday)
01/07/20 BofA
PLDT upgraded to Neutral from Underperform at BofA
01/06/20 Citi
PLDT upgraded to Neutral from Sell at Citi
DOX Amdocs
$59.01 /

+1.22 (+2.11%)

DOX Amdocs
$59.01 /

+1.22 (+2.11%)

Earnings
Axonics reports preliminary Q2 revenue $15.2M, consensus $5.19M » 06:07
07/13/20
07/13
06:07
07/13/20
06:07
AXNX

Axonics

$39.35 /

-1.88 (-4.56%)

Sales to customers in the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXNX Axonics
$39.35 /

-1.88 (-4.56%)

AXNX Axonics
$39.35 /

-1.88 (-4.56%)

04/21/20 Piper Sandler
Axonics price target lowered to $44 from $48 at Piper Sandler
04/14/20 Piper Sandler
Axonics next-gen INS not compatible with InterStim II leads, says Piper Sandler
04/08/20 Wells Fargo
Axonics price target lowered to $35 from $47 at Wells Fargo
03/05/20 SunTrust
Axonics price target raised to $48 from $38 at SunTrust
AXNX Axonics
$39.35 /

-1.88 (-4.56%)

  • 08
    May
  • 20
    Nov
AXNX Axonics
$39.35 /

-1.88 (-4.56%)

Initiation
TAL Education resumed with a Buy at BofA » 06:07
07/13/20
07/13
06:07
07/13/20
06:07
TAL

TAL Education

$73.58 /

-2.88 (-3.77%)

BofA analyst Lucy Yu…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TAL TAL Education
$73.58 /

-2.88 (-3.77%)

TAL TAL Education
$73.58 /

-2.88 (-3.77%)

06/30/20 Goldman Sachs
TAL Education price target raised to $75 from $64 at Goldman Sachs
04/13/20 CLSA
TAL Education downgraded to Sell from Outperform at CLSA
04/08/20 GLJ Research
JinkoSolar price target lowered to $6.88 from $7.97 at GLJ Research
03/23/20 DBS Holding
TAL Education upgraded to Buy from Hold at DBS Holding
TAL TAL Education
$73.58 /

-2.88 (-3.77%)

TAL TAL Education
$73.58 /

-2.88 (-3.77%)

TAL TAL Education
$73.58 /

-2.88 (-3.77%)

Recommendations
Netflix price target raised to $625 from $500 at BMO Capital » 06:06
07/13/20
07/13
06:06
07/13/20
06:06
NFLX

Netflix

$548.56 /

+40.65 (+8.00%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$548.56 /

+40.65 (+8.00%)

NFLX Netflix
$548.56 /

+40.65 (+8.00%)

07/10/20 Goldman Sachs
Netflix price target raised to $670 from $540 at Goldman Sachs
07/10/20 Piper Sandler
Piper search index suggests inline Q2 sub results for Netflix
07/09/20 JPMorgan
JPMorgan raises Netflix sub addition estimate above Q2 guidance
07/08/20 Stifel
Netflix price target raised to $500 from $460 at Stifel
NFLX Netflix
$548.56 /

+40.65 (+8.00%)

NFLX Netflix
$548.56 /

+40.65 (+8.00%)

NFLX Netflix
$548.56 /

+40.65 (+8.00%)

NFLX Netflix
$548.56 /

+40.65 (+8.00%)

NFLX Netflix
$548.56 /

+40.65 (+8.00%)

Recommendations
U.S. Gold price target raised to $16.50 from $14.50 at H.C. Wainwright » 06:06
07/13/20
07/13
06:06
07/13/20
06:06
USAU

U.S. Gold

$7.40 /

+0.75 (+11.28%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
USAU U.S. Gold
$7.40 /

+0.75 (+11.28%)

Hot Stocks
Himax names Jessica Pan as CFO, Eric Li as Chief IR/PR Officer » 06:05
07/13/20
07/13
06:05
07/13/20
06:05
HIMX

Himax

$3.89 /

-0.055 (-1.40%)

Himax Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HIMX Himax
$3.89 /

-0.055 (-1.40%)

HIMX Himax
$3.89 /

-0.055 (-1.40%)

05/08/20 Lake Street
Himax challenges not due to change in competitive position, says Lake Street
04/01/20 Lake Street
Lake Street confident Himax positioned to see continued momentum
03/25/20 Baird
Himax emerging from transition, re- initiated with an Outperform at Baird
03/25/20 Baird
Himax reinstated with an Outperform at Baird
HIMX Himax
$3.89 /

-0.055 (-1.40%)

HIMX Himax
$3.89 /

-0.055 (-1.40%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.